CIK: 0001977548 · Show all filings
Period: Q3 2024 (← Previous) (Next →)
Filing Date: Nov 14, 2024
Total Value ($000): $201,574 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ARGX | ARGENX SE | 92,500 | $50,142 | 24.9% | $400.24 | — | SPONSORED ADR | 04016X101 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 663,381 | $34,755 | 17.2% | $33.69 | +42.2% | COM | 76243J105 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 1,504,307 | $27,198 | 13.5% | $11.33 | +23.3% | COM | 71722W107 |
| CYTK | CYTOKINETICS INC | 466,813 | $24,648 | 12.2% | $47.79 | +16.6% | COM NEW | 23282W605 |
| AXSM | AXSOME THERAPEUTICS INC | 209,632 | $18,840 | 9.3% | $70.77 | +23.3% | COM | 05464T104 |
| — | AVADEL PHARMACEUTICALS PLC | 1,100,000 | $14,427 | 7.2% | $14.06 | — | COM SHS | G29687103 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 240,000 | $10,800 | 5.4% | $20.35 | +98.6% | COM | 74366E102 |
| PLRX | PLIANT THERAPEUTICS INC | 380,000 | $4,260 | 2.1% | $12.74 | -1.8% | COM | 729139105 |
| TCRX | TSCAN THERAPEUTICS INC | 825,341 | $4,110 | 2.0% | $6.03 | 0.0% | COM | 89854M101 |
| ATYR | ATYR PHARMA INC | 1,736,477 | $3,056 | 1.5% | $1.40 | +30.0% | COM NEW | 002120202 |
| SLNO | SOLENO THERAPEUTICS INC | 57,983 | $2,928 | 1.5% | $46.01 | +4.1% | COM | 834203309 |
| — | CIDARA THERAPEUTICS INC | 182,426 | $1,961 | 1.0% | $11.70 | — | COM NEW | 171757206 |
| STOK | STOKE THERAPEUTICS INC | 157,514 | $1,936 | 1.0% | $14.17 | 0.0% | COM | 86150R107 |
| IRON | DISC MEDICINE INC | 25,543 | $1,255 | 0.6% | $46.95 | 0.0% | COM | 254604101 |
| TRVI | TREVI THERAPEUTICS INC | 250,000 | $835 | 0.4% | $1.51 | +96.4% | COM | 89532M101 |
| — | ALLAKOS INC | 649,957 | $425 | 0.2% | $2.11 | — | COM | 01671P100 |